Skip to content
case study
CLINICAL CASE: PATIENT WITH ANEMIA SECONDARY TO INC
Treated with Fertop 30cpr
Dr. Raphael Marino
Physician Specializing in Nephrology
ASL Casoria
Mr. Francis S. was treated with Fertop 30cpr for anemia secondary to INC, had followed other therapies with partial report showing significant improvement in episodes of anemia and blood stasis, with increased hemoglobin.
Therapy: Fertop 30cpr at a dosage of one tablet twice daily for 10 days.
Then one tablet daily for three months starting 8/7/2022.
The results have been excellent.
Dr. Raphael Marino
Share the article on your socials!
Facebook
LinkedIn
Telegram
X
Stay up to date*, sign up for our Science Newsletter to receive every article on your email!
You may also be interested in.
-
STUDIO SU UN NUTRACEUTICO ED UNA LOZIONE FITOTERAPICA IN DONNE CON ALOPECIA FEMMINILE POST-MENOPAUSA -
THE USE OF GINKGO BILOBA EXTRACT IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME -
ON THE USE OF SPECIFIC NUTRACEUTICALS AS ADJUNCTS TO TREATMENTS FOR ADHD -
THEY TALK ABOUT TRIVIS UV ON “THE SKIN” -
ON THE BENEFITS OF HYALURONIC ACID ON SCALP AND FOLLICLES
Products in this article:
Fertop
FERTOP is a complete and well-tolerated microencapsulated iron pyrophosphate product for all cases of iron deficiency, Telogen Effluvium and Sideropenia
